News & Events

Physicians, scientists, and trainees fromYale Cancer Center and Smilow Cancer Hospital attended the 66th annual meeting of the American Society of Hematology in San Diego, CA, December 7-10, 2024 to present the latest advances in hematological research and clinical care from Yale.

A listing of recent publications by Yale Cancer Center researchers and clinicians in the first quarter of 2024

Angiopoietin-like 4 (ANGPTL4) promotes kidney fibrosis and the progression of diabetic kidney disease, animal models reveal. Targeting this protein could lead to new treatments.

Yale Cancer Center and Smilow Cancer Hospital people who have been honored

The first comprehensive review of outcomes among all face transplant patients shows an 85% five-year success rate.

Research examining health conditions unique to women, more prevalent in women, or affecting women differently than men have been at the heart of Women’s Health Research at Yale since its founding in 1998.

Erol Fikrig, MD, is honored for his work leading to a Lyme disease vaccine, and Haifan Lin, PhD, is recognized for two "hallmark" stem cell theories.

The Katz Lab in the Department of Pathology was recently awarded a National Institutes of Health grant to study the role of a protein called BOK in cell death of neurons.

Aging is a natural process that unfolds as our bodies move through different stages of life. Research focused on aging is an interdisciplinary field, transcending geriatrics and spanning throughout internal medicine, public health, and many other disciplines. In recent years, the Yale Claude D. Pepper Older Americans Independence Center has focused on building partnerships and increasing resources on campus for faculty and trainees interested in pursuing aging research.